Small babies on a small island: survival of very low birthweight infants in Antigua and Barbuda 1986 to 2006 / Bebés pequeños en islas pequeñas: supervivencia de infantes con muy bajo peso al nacer en Antigua y Barbuda, de 1986 a 2006

INTRODUCTION: Recent attention has been focussed on pregnancy outcomes in developing countries, with the publication of the World Health Organization Report 2005, Make Every Mother and Child Count and the Neonatal Survival Series from the Lancet in 2005. Scant outcome data from the smaller islands of the Caribbean exist for very low birthweight (VLBW) babies (birthweight < 1500 g). PATIENTS AND METHODS: a retrospective review of mortality data on vlbw babies in antigua and barbuda was performed. antigua and barbuda had a population of 71 500 with per capita income of (us) $6054 dollars in 1998. in november 1985, a neonatal special care nursery (scn) was established. the survival to discharge from scn for vlbw babies was reviewed from january 1986 to december 2006. RESULTS: there were 26 455 babies born from 1986 to 2006; 344 (1.3%) were vlbw babies. survival to scn discharge was 45% from 1986 to 1992, 46% from 1993 to 1999, and increased to 60% from 2000 to 2006 (p < 0.05 compared with the first two time-periods). babies from 1000 to 1499 g accounted for 64% of vlbw babies and survival to scn discharge was 60% from 1986 to 1992, 58% from 1993 to 1999, and increased to 83% from 2000 to 2006 (p < 0.01 compared with the first time period; p < 0.001 compared with the second). babies < 1000g accounted for 36% of VLBW babies and survival to SCN discharge was 10% from 1986 to 1992, increased to 25% from 1993 to 1999 and to 28% from 2000 to 2006 (trend of p < 0.10 compared with first time period). conservative newborn care only was available. antenatal steroids were given from 2000 to 2006. CONCLUSION: the outlook for vlbw babies using conservative newborn care techniques has significantly improved over 21-years in antigua and barbuda.

INTRODUCCIÓN: Recientemente se ha centrado la atención en los resultados del embarazo en los países en vías de desarrollo, a partir de la publicación del Informe 2005 de la Organización Mundial de la Salud, Que cada madre y cada niño cuente y la Serie de Supervivencia Neonatal de la Lancet en 2005. Son escasos los datos de resultados existentes en las islas más pequeñas del Caribe, acerca de los bebés con muy bajo peso al nacer (MBPN) (peso al nacer < 1500 g). PACIENTES Y MÉTODOS: se llevó a cabo una revisión retrospectiva de datos sobre la mortalidad de bebés mbpn en antigua y barbuda. antigua y barbuda tenían una población de 71 500 con un ingreso per cápita de $6054 usd en 1998. en noviembre de 1985, se creó una sala de cuidados especiales del Recién Nacido (SCN). La supervivencia en término de los bebés MBPN dados de alta de la SCN fue examinada de enero de 1986 a diciembre de 2006. RESULTADOS: De 1986 a 2006, hubo 26 455 bebés nacidos; de ellos 344 (1.3%) fueron bebés MBPN. La supervivencia en término de las altas de la SCN fue de 45% de 1986 a 1992, 46% de 1993 a 1999, y aumentó a 60% de 2000 a 2006 (p <0.05 en comparación con los primeros dos períodos de tiempo). Los bebés de 1000 a 1499g representaron el 64% de los bebés MBPN y la cifra de los supervivientes dados de alta del SCN fue de 60% de 1986 a 1992, 58% de 1993 a 1999, y aumentó a 83% de 2000 a 2006 (p < 0.01 en comparación con el primer periodo de tiempo; p <0.001 en comparación con el segundo). Los bebés <1000 g representaron el 36% de los bebés MBPN, y la supervivencia en términos de los dados de alta de la SCN fue 10% de 1986 a 1992, aumentó a 25% de 1993 a 1999, y a 28% de 2000 a 2006 (la tendencia de p <0.10 en comparación con el primer periodo de tiempo). Sólo hubo disponible atención neonatal conservadora Se administraron esteroides antenatales desde el año 2000 al 2006. CONCLUSIÓN: El pronóstico para MBPN usando técnicas de cuidado neonatal conservadoras ha mejorado significativamente a lo largo de 21 años en Antigua y Barbuda.

Rescue of the Corpus luteum from luteolysis by bovine trophoblast protein-1: an example of maternal recognition of pregnancy

Bovine trophoblast protein-1 (bTP-1) is an interferon molecule produced by trophectoderm tissue that plays a critical role in maintenance of luteal function during early pregnancy. Synthesis and secretion of bTP-1 begins as early as day 10 of pregnancy, is maximal around days 15-22, and continues to at least day 25. Bovine trophoblast protein-1 exists as a complex of up to 13 microheterogeneous glycoproteins in three molecular weight classes (21-22 kDa, 23-24 kDa and 26 kDa), with each molecular weight class having 4-5 isoelectric variants of pI 5.6-6.6. The several isoelectric variants of bTP-1 arise from different mRNA and the different size classes from differences in degree of glycosylation. As for other interferon-* molecules, bTP-1 possesses antiviral activity and inhibits lymphocyte proliferation. The major role of bTP-1, however, is to block endometrial secretion of prostaglandin F2* so as to prevent luteolysis. This effect of bTP-1 may be exerted through induction of an inhibitor in endometrial epithelial cells that blocks the conversion of arachidonic acid to prostaglandins. Interestingly, other interferon-* molecules can also block secretion of endometrial PGF2* in vitro and one of these, bovine interferon-*1 1, has been shown to be effective in extending luteal lifespan when administered intramuscularly. This latter finding raises the possibility of using systemically-administered bTP-1 or other interferon-* molecules for enhancing fertility. Before such schemes can be feasible, however procedures must be found to minimize side effects of interferon administration such as hyperthermia and a transient depression in circulating progesterone concentrations. Future research on bTP-1 will concentrate on developing practical systems for fertility enhancement using bTP-1 or related interferons as well as on problems of mechanism of action of bTP-1 and regulation of expression of the bTP-1 gene in trophectoderm